AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
BUPRENORPHINE in Tunisia
4 products registered with DPM — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BUTRANS Dispositif trans-dermique / 5µG/H | 16263032 | Napp Pharmaceuticals Limited | expired | 15 Mar 2021 |
| BUTRANS Dispositif trans-dermique / 10µG/H | 1626301 | Napp Pharmaceuticals Limited | expired | 15 Mar 2021 |
| BUTRANS Dispositif trans-dermique / 20µG/H | 16263033 | Napp Pharmaceuticals Limited | expired | 15 Mar 2021 |
| TEMGESIC Solution injectable / 0.300 MG | 6523041BH | SCHERING-PLOUGH SA | expired | 13 Feb 1991 |
BUPRENORPHINE — DPM Registration Details
DPM (Tunisia) has 4 registered products containing BUPRENORPHINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track BUPRENORPHINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.